9 results about "Dietary Formulations" patented technology

This document describes poultry diets containing phytase polypeptides or fragments thereof, in which the diet contains no or practically no inorganic phosphate.

A pet care service management system including a transceiver, a memory and a processor is disclosed. The transceiver may receive pet information from a user device, which may include symptom information and diet preference information associated with a pet. The memory may store a mapping between a plurality of pet conditions and a plurality of recommended diets. The processor may estimate a pet condition based on the symptom information, and determine a preliminary diet for the pet by correlating the pet condition with the mapping. The processor may further determine an adjusted diet recipe for the pet based on the preliminary diet and the diet preference information. The processor may additionally transmit information associated with the adjusted diet recipe to the user device.

The invention aims to disclose a special dietary preparation based on alpha-ketoglutaric acid as well as a preparation process and application thereof, and relates to the technical field of dietary supplements. Every 800 mg of the dietary preparation comprises 50 mg to 100 mg of alpha-ketoglutaric acid or alpha-ketoglutaric acid salt, 5 mg to 12 mg of N-acetylneuraminic acid or N-acetylneuraminic acid salt, 30 mg to 60 mg of ergothioneine, 100 mg to 150 mg of a desert cistanche deserticola water extract or 50 mg to 80 mg of desert cistanche deserticola total glycosides, and auxiliary materials. The alpha-ketoglutaric acid salt is any one or more of alpha-ketoglutaric acid calcium, alpha-ketoglutaric acid sodium and alpha-ketoglutaric acid magnesium; the N-acetylneuraminic acid salt is any one or more of N-acetylneuraminic acid calcium, N-acetylneuraminic acid sodium and N-acetylneuraminic acid magnesium; the special dietary preparation has the beneficial effects that the special dietary preparation simultaneously contains alpha-ketoglutaric acid or alpha-ketoglutaric acid salt, N-acetylneuraminic acid or N-acetylneuraminic acid salt, ergothioneine and the cistanche deserticola aqueous extract, and has the effects of delaying senescence, resisting fatigue, improving the symptom of kidney-yang deficiency and enhancing immunity for males aged more than 45 years old.

Female and male mice were weighed the same day each week in nine mouse rooms representing all three breeding facilities. Weights were measured from 40 females and 40 males in each room; the values shown here represent averages of up to 360 females and 360 mates. Mice were fed a diet containing 6% fat (LabDiet® 5K52 formulation). Values represent mean and one standard deviation. Ages are ±3 days.

The present disclosure describes the use of an emulsifier derived from ricinoleic acid for increasing the absorption of calcium and phosphorus in the digestive tract of a farm animal. In addition, the present disclosure provides compositions and dietary formulations containing emulsifier derivatives of ricinoleic acid and methods of producing the same.

This invention discloses a synergistic, low-carbohydrate, low-uric acid diet system and its application in regulating hyperuricemia. The basic dietary formula consists of synergistically low-carbohydrate staple foods, low-carbohydrate vegetables, low-purine proteins, low-fructose fruits, special oils, and beverages, formulated according to the three-low standards. The nutritional supplement system includes vitamin D3, MK-7 vitamin K2, magnesium glycine, fish oil, and various minerals. Special preparation methods include micro-fermentation / micro-germination of staple foods, static processing of vegetables, and low-temperature cooking of proteins. Differentiated implementation rules are tailored to different types of hyperuricemia, populations, comorbidities, and complications. All ingredients meet the three-low standards: absorbable net carbohydrates ≤30g / 100g (staple foods) or ≤20g / 100g (non-staple foods), purines ≤50mg / 100g, and fructose ≤5g / 100g. Clinical trials show that the formula of this invention can reduce blood uric acid by 24.76%, improve complications by 91.0%, achieve compliance of 95.0%, and demonstrate good safety.

This disclosure provides a low-fat, low-irritation, nutritionally complete food composition for companion animals containing approximately 50 to approximately 80 g / Mcal of protein, wherein the protein comprises at least approximately 80% hydrolyzed protein, approximately 120 to approximately 180 g / Mcal of starch, wherein the starch comprises at least one rice source, approximately 10 to approximately 30 g / Mcal of total food fiber (TDF), and less than approximately 25 g / Mcal of fat. The composition can be used for companion animals suffering from adverse food reactions (AFRs) such as concomitant hyperlipidemia, lymphangiectasia, or any form of fat intolerance, fat malabsorption, and / or chronic intestinal disease.

The present disclosure describes the use of an emulsifier derived from ricinoleic acid to increase the absorption of calcium and phosphorus in the digestive tract of farm animals. Additionally, the present disclosure provides a composition and a dietary formulation containing an emulsifier derivative of ricinoleic acid and its production method.

Provided herein are poultry diets containing phytase polypeptides or fragments thereof wherein the diet contains no or substantially no inorganic phosphate.